Background Ustekinumab is a human interleukin-12 and -23 antagonist used in treatment of inflammatory bowel diseases (IBD). In this indication, it is delivered by single weight-dependant intravenous ...

Eisai is seeking approval for an injectable version of Leqembi while Eli Lilly is developing a new injectable drug. These ...

12–17yrs: 115mg IV once over 30mins on Day 1 ... Severe hepatic impairment. Injection: monitor for infusion site or hypersensitivity reactions; discontinue and treat appropriately if occur ...